Lachlan Brown
Stock Analyst at William Blair
(0.20)
# 4,057
Out of 4,814 analysts
8
Total ratings
14.29%
Success rate
-14.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lachlan Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KLRS Kalaris Therapeutics | Initiates: Outperform | n/a | $7.01 | - | 1 | Apr 8, 2025 | |
| OCUL Ocular Therapeutix | Initiates: Outperform | n/a | $7.34 | - | 1 | Apr 8, 2025 | |
| SNPS Synopsys | Initiates: Buy | $600 | $413.32 | +45.17% | 1 | Jan 13, 2025 | |
| CDNS Cadence Design Systems | Initiates: Buy | $350 | $260.22 | +34.50% | 1 | Jan 13, 2025 | |
| APLS Apellis Pharmaceuticals | Initiates: Outperform | n/a | $18.17 | - | 1 | Oct 16, 2024 | |
| DSGX The Descartes Systems Group | Initiates: Neutral | $90 | $102.40 | -12.11% | 1 | May 14, 2024 | |
| MANH Manhattan Associates | Initiates: Buy | $260 | $162.36 | +60.14% | 1 | May 14, 2024 | |
| SPSC SPS Commerce | Initiates: Buy | $220 | $129.06 | +70.46% | 1 | May 14, 2024 |
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $7.01
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $7.34
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $413.32
Upside: +45.17%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $260.22
Upside: +34.50%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $18.17
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $102.40
Upside: -12.11%
Manhattan Associates
May 14, 2024
Initiates: Buy
Price Target: $260
Current: $162.36
Upside: +60.14%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $129.06
Upside: +70.46%